Time to appropriate treatment in patients with multidrug-resistant tuberculosis in South Korea: Are we still in 2010?
Eun-Jung JoSeyeon ParkKyu Min LeeInsu KimJung Seop EomMi-Hyun KimKwangha LeeKi Uk KimHye-Kyung ParkMin Ki LeeJeong Ha MokPublished in: PloS one (2019)
The time to appropriate treatment in patients with MDR-TB in South Korea was not acceptable, particularly for patients diagnosed outside of PNUH and for patients with pre-XDR- or XDR-TB. The use of rapid molecular drug susceptibility tests in various healthcare settings and introduction of second-line LPAs are required.
Keyphrases
- multidrug resistant
- healthcare
- drug resistant
- mycobacterium tuberculosis
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- acinetobacter baumannii
- peritoneal dialysis
- prognostic factors
- gram negative
- combination therapy
- single molecule
- pseudomonas aeruginosa
- social media
- klebsiella pneumoniae
- hiv infected
- adverse drug
- health information
- patient reported
- sensitive detection